Position in SCLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$19
-$115 QoQ
Shares Held
3
-72.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $1,669,332,547 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
503,731 | $463,316,658 | |
| 2 | JNJ |
Johnson & Johnson
|
1,054,990 | $257,881,753 | |
| 3 | AMGN |
Amgen Inc
|
643,944 | $226,571,694 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,752,898 | $210,856,097 | |
| 5 | ABBV |
AbbVie Inc.
|
911,994 | $198,349,572 | |
| 6 | AZN |
Astrazeneca PLC
|
473,389 | $93,361,776 | |
| 7 | PFE |
Pfizer Inc
|
1,984,826 | $55,733,911 | |
| 8 | NVO |
Novo Nordisk A S
|
1,433,073 | $52,665,431 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19 | 3 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $134 | 11 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $137 | 7 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||